You're in the right place! Welcome to our newly updated ESC website.
Start exploring or use our powerful new search engine to find what you need. 

Arrhythmic mitral valve prolapse: where do we stand?

In this podcast, Dr. Maurice Enriquez-Sarano (The Allina Heart Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, USA) joins Dr. Marc Ferrini (Editor-in-Chief CardioPractice; CH Saint Joseph and Saint Luc, Lyon, France) to discuss our current understanding of mitral valve prolapse (MVP). The treatment of MVP has evolved in recent years, and we now know that a small fraction of myxomatous mitral valve prolapse patients may, over time, experience severe arrhythmia, irrespective of mitral regurgitation severity. Dr. Sarano presents the current thinking on the diagnosis and the tools available for arrhythmic risk stratification.

Arrhythmic mitral valve prolapse: where do we stand? - video

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.